ArticleCureus2026
Recurrence of B-cell Lymphoma Manifesting as Progressive Peripheral and Cranial Nerve Neuropathies: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurolymphomatosis (NL) is a rare neurological complication of lymphoma, characterised by direct infiltration of peripheral nerves by neoplastic cells. It most commonly occurs in association with non-Hodgkin's lymphoma (NHL) and poses significant diagnostic challenges due to its non-specific clinical presentation. Classically, NL presents as a painful, rapidly progressive, and asymmetric neuropathy, frequently mimicking inflammatory or vasculitic neuropathies. Here, we present the case of a 69-year-old woman with a history of NHL, in remission for five years, who presented with a progressive, asymmetric sensorimotor polyneuropathy that later progressed to include several cranial nerve palsies. Initial investigations demonstrated features of chronic inflammatory axonal polyneuropathy. The patient's atypical clinical progression and poor response to immunosuppressive therapy prompted further evaluation. A CT-guided sciatic nerve biopsy, based on fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging, facilitated the histopathological analysis that confirmed infiltration by malignant B lymphocytes, establishing a diagnosis of secondary NL. Targeted therapy with zanubrutinib led to marked neurological improvement, although she ultimately passed away. This case highlights the importance of maintaining a high index of suspicion for NL in patients with atypical or refractory neuropathies and a history of lymphoma and underscores the diagnostic value of FDG-PET imaging and nerve biopsy in guiding accurate diagnosis and delivery of crucial early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.